Morawietz, Henning

Dose-Dependent Regulation of NAD(P)H Oxidase Expression by Angiotensin II in Human Endothelial Cells: Protective Effect of Angiotensin II Type 1 Receptor Blockade in Patients With Coronary Artery Disease

Rueckschloss, U., Quinn, M. T., Holtz, J., & Morawietz, H. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology

Nitric Oxide and Endothelin EffectsRenin-Angiotensin System Studies

Cited by 216

NADPH oxidase 4 protects against development of endothelial dysfunction and atherosclerosis in LDL receptor deficient mice

Langbein, H., Brunssen, C., Hofmann, A., Cimalla, P., Brux, M., Bornstein, S. R., Deussen, A., Koch, E., & Morawietz, H. (2016) · European Heart Journal

Nitric Oxide and Endothelin EffectsRedox biology and oxidative stress

Cited by 133

Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis

Punch, E., Klein, J., Diaba‐Nuhoho, P., Morawietz, H., & Garelnabi, M. (2022) · Journal of the American Heart Association

Atherosclerosis and Cardiovascular DiseasesLipoproteins and Cardiovascular Health

Cited by 101

Differential roles of PKCα and PKCɛ in controlling the gene expression of Nox4 in human endothelial cells

Xu, H., Goettsch, C., Xia, N., Horke, S., Morawietz, H., Förstermann, U., & Li, H. (2008) · Free Radical Biology and Medicine

Nitric Oxide and Endothelin EffectsRedox biology and oxidative stress

Cited by 89

Contribution of lectin-like oxidized low-density lipoprotein receptor-1 and LOX-1 modulating compounds to vascular diseases

Hofmann, A., Brunssen, C., & Morawietz, H. (2018) · Vascular Pharmacology

Atherosclerosis and Cardiovascular DiseasesNitric Oxide and Endothelin Effects

Cited by 68